John Gutheil

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of <i>HER2</i>-Overexpressing Metastatic Breast Cancer

Charles L. Vogel, Melody Cobleigh, Debu Tripathy et al. · Journal of Clinical Oncology · 2002 · 1.8K citations

Breast Oncology, Single Agent, Medicine +13

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Gerald Batist, Gopal Ramakrishnan, Chandra Sekhar Rao et al. · Journal of Clinical Oncology · 2001 · 653 citations

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20⁺B-Cell Non-Hodgkin's Lymphoma

Thomas E. Witzig, Christine A. White, Gregory A. Wiseman et al. · Journal of Clinical Oncology · 1999 · 538 citations

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle et al. · Journal of Clinical Oncology · 1999 · 398 citations

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 231 citations

Urology, Open Label, Genitourinary Cancer +7